CATO 佳途CATO · CNAS + ANAB ISO 17034 双体系认可标准物质生产者CNAS + ANAB ISO 17034 dual-accredited reference material producer
销售顾问Sales contact 卢振明Kaka Lu+86 185 2048 1969kaka@cato-chem.com
Roxatidine

罗沙替丁 杂质对照品Roxatidine Impurities

35 个杂质条目35 impurity entries

本页汇总 罗沙替丁 的 35 个杂质对照品条目。杂质谱是仿制药杂质研究、方法开发与稳定性考察的起点——先锁定品种,再逐条比对结构差异与保留行为。This page collects 35 impurity reference standards of Roxatidine. The impurity profile is the starting point for related-substance method development, forced degradation and stability studies.

批量索取报价 / COABulk quote / COA在全站目录中检索Search the full catalogue

相关研究文献Related literature

以下为 罗沙替丁(Roxatidine)在公开文献中的研究报道(题录信息,来源 PubMed),供方法开发与文献调研参考。Selected peer-reviewed publications on this drug substance — bibliographic records from PubMed.

  1. 分析方法Analytical MethodsQuantification of roxatidine in human plasma by liquid chromatography electrospray ionization tandem mass spectrometry: application to a bioequivalence study
    Journal of chromatography. B, Analytical technologies in the biomedical and life sciences · 2008 · Ryu JH et al.  ·  PMID 18977187  ·  DOI
  2. 分析方法Analytical MethodsDetermination of roxatidine in human plasma by liquid chromatography/electrospray mass spectrometry and application to a clinical pharmacokinetic study
    Rapid communications in mass spectrometry : RCM · 2007 · Shin BS et al.  ·  PMID 17200973  ·  DOI
  3. 分析方法Analytical MethodsDetermination of roxatidine in human plasma, urine and milk by capillary gas chromatography using nitrogen-selective detection
    Journal of chromatography · 1988 · Burrows JL et al.  ·  PMID 2906063  ·  DOI

合成路线参考Reported synthetic routes

以下为公开文献中报道的合成方法(题录信息)。标题多已点明关键反应,可据此查阅原文了解完整路线与工艺条件。Published synthetic approaches. Titles usually name the key transformation; consult the original articles for full routes.

  • 合成方法SynthesisRoles of extracellular Ca++ and calmodulin in roxatidine-stimulated secretion and synthesis of mucus by cultured rabbit gastric mucosal cells
    The Journal of pharmacology and experimental therapeutics · 1998 · Takahashi S, Okabe S  ·  PMID 9435158

罗沙替丁 —— 原料药与杂质对照品Roxatidine — drug substance & impurities

共 36 个条目(含原料药本体)36 items incl. the drug substance
Roxatidine structure
原料药 APIAPI
罗沙替丁Roxatidine
Roxatidine
CAS No.78273-80-0
Chemical FormulaC17H26N2O3
Purity>95%询价On request
10mg25mg50mg100mg
Roxatidine Hemioxalate structure
—
罗沙替丁 半草酸盐Roxatidine Hemioxalate
Roxatidine Hemioxalate
CAS No.110925-92-3
Chemical FormulaC17H26N2O3·1/2(C2H2O4)
Purity>95%询价On request
10mg25mg50mg100mg
Roxatidine Impurity 1 structure
1
罗沙替丁杂质1Roxatidine Impurity 1
Roxatidine Impurity 1
CAS No.73279-04-6
Chemical FormulaC12H17NO
Purity>95%询价On request
10mg25mg50mg100mg
Roxatidine Impurity 2 Monomer(Roxatidine Acetate Hydrochloride Monomer) structure
2
罗沙替丁杂质2 单体(罗沙替丁醋酸盐 单体)Roxatidine Impurity 2 Monomer(Roxatidine Acetate Hydrochloride Monomer)
Roxatidine Impurity 2 Monomer(Roxatidine Acetate Hydrochloride Monomer)
CAS No.78628-28-1
Chemical FormulaC19H28N2O4
Purity>95%询价On request
10mg25mg50mg100mg
Roxatidine Impurity 2 (Roxatidine Acetate Hydrochloride) structure
2
罗沙替丁杂质2(盐酸罗沙替丁醋酸盐)Roxatidine Impurity 2 (Roxatidine Acetate Hydrochloride)
Roxatidine Impurity 2 (Roxatidine Acetate Hydrochloride)
CAS No.93793-83-0
Chemical FormulaC19H29ClN2O4
Purity>95%询价On request
10mg25mg50mg100mg
Roxatidine Impurity 3 structure
3
罗沙替丁杂质3Roxatidine Impurity 3
Roxatidine Impurity 3
CAS No.100-83-4
Chemical FormulaC7H6O2
Purity>95%询价On request
10mg25mg50mg100mg
Roxatidine Impurity 6 structure
6
罗沙替丁杂质6Roxatidine Impurity 6
Roxatidine Impurity 6
CAS No.876497-65-3
Chemical FormulaC7H6N2O2
Purity>95%询价On request
10mg25mg50mg100mg
Roxatidine Impurity 7 structure
7
罗沙替丁杂质7Roxatidine Impurity 7
Roxatidine Impurity 7
CAS No.87327-60-4
Chemical FormulaC4H6O4
Purity>95%询价On request
10mg25mg50mg100mg
Roxatidine Impurity 8 Monomer structure
8
罗沙替丁杂质8 单体Roxatidine Impurity 8 Monomer
Roxatidine Impurity 8 Monomer
CAS No.78273-74-2
Chemical FormulaC17H26N2O2
Purity>95%询价On request
10mg25mg50mg100mg
Roxatidine Impurity 8 structure
8
罗沙替丁杂质8Roxatidine Impurity 8
Roxatidine Impurity 8
CAS No.97900-87-3
Chemical FormulaC17H26N2O2·HCl
Purity>95%询价On request
10mg25mg50mg100mg
Roxatidine Impurity 9 structure
9
罗沙替丁杂质9Roxatidine Impurity 9
Roxatidine Impurity 9
CAS No.195621-06-8
Chemical FormulaC15H24N2O·HCl
Purity>95%询价On request
10mg25mg50mg100mg
Roxatidine Impurity 9 Monomer structure
9
罗沙替丁杂质9 单体Roxatidine Impurity 9 Monomer
Roxatidine Impurity 9 Monomer
CAS No.73278-98-5
Chemical FormulaC15H24N2O
Purity>95%询价On request
10mg25mg50mg100mg
Roxatidine Impurity 10 structure
10
罗沙替丁杂质10Roxatidine Impurity 10
Roxatidine Impurity 10
CAS No.78274-00-7
Chemical FormulaC16H24N2O2
Purity>95%询价On request
10mg25mg50mg100mg
Roxatidine Impurity 14 structure
14
罗沙替丁杂质14Roxatidine Impurity 14
Roxatidine Impurity 14
CAS No.2765350-61-4
Chemical FormulaC18H31N3O
Purity>95%询价On request
10mg25mg50mg100mg
Roxatidine Impurity 18 structure
18
罗沙替丁杂质18Roxatidine Impurity 18
Roxatidine Impurity 18
CAS No.2765350-63-6
Chemical FormulaC26H39N3O7
Purity>95%询价On request
10mg25mg50mg100mg
Roxatidine Impurity 19 structure
19
罗沙替丁杂质19Roxatidine Impurity 19
Roxatidine Impurity 19
CAS No.108441-34-5
Chemical FormulaC17H25ClN2O2
Purity>95%询价On request
10mg25mg50mg100mg
Roxatidine Impurity 24 structure
24
罗沙替丁杂质24Roxatidine Impurity 24
Roxatidine Impurity 24
CAS No.853574-98-8
Chemical FormulaC7H12ClNO3
Purity>95%询价On request
10mg25mg50mg100mg
Roxatidine Impurity 31 structure
31
罗沙替丁杂质31Roxatidine Impurity 31
Roxatidine Impurity 31
CAS No.1507587-68-9
Chemical FormulaC10H15NO2
Purity>95%询价On request
10mg25mg50mg100mg
Roxatidine Impurity 33 structure
33
罗沙替丁杂质33Roxatidine Impurity 33
Roxatidine Impurity 33
CAS No.106871-89-0
Chemical FormulaC15H22N2O2
Purity>95%询价On request
10mg25mg50mg100mg
Roxatidine Impurity 38 structure
38
罗沙替丁杂质38Roxatidine Impurity 38
Roxatidine Impurity 38
CAS No.132284-19-6
Chemical FormulaC5H11NO3
Purity>95%询价On request
10mg25mg50mg100mg
Roxatidine Impurity 40 structure
40
罗沙替丁杂质40Roxatidine Impurity 40
Roxatidine Impurity 40
CAS No.616238-94-9
Chemical FormulaC4H4O6
Purity>95%询价On request
10mg25mg50mg100mg
Roxatidine Impurity 42 structure
42
罗沙替丁杂质42Roxatidine Impurity 42
Roxatidine Impurity 42
CAS No.1211493-82-1
Chemical FormulaC5H9NO4
Purity>95%询价On request
10mg25mg50mg100mg
Roxatidine Impurity 47 structure
47
罗沙替丁杂质47Roxatidine Impurity 47
Roxatidine Impurity 47
CAS No.73279-03-5
Chemical FormulaC15H24N2O
Purity>95%询价On request
10mg25mg50mg100mg
Roxatidine Impurity 49 structure
49
罗沙替丁杂质49Roxatidine Impurity 49
Roxatidine Impurity 49
CAS No.30450-85-2
Chemical FormulaC4H6O5
Purity>95%询价On request
10mg25mg50mg100mg
Roxatidine Impurity 53 structure
53
罗沙替丁杂质53Roxatidine Impurity 53
Roxatidine Impurity 53
CAS No.39143-25-4
Chemical FormulaC13H18N2O2
Purity>95%询价On request
10mg25mg50mg100mg
Roxatidine Impurity 54 structure
54
罗沙替丁杂质54Roxatidine Impurity 54
Roxatidine Impurity 54
CAS No.28936-94-9
Chemical FormulaC14H17N3O2
Purity>95%询价On request
10mg25mg50mg100mg
Roxatidine Impurity 55 structure
55
罗沙替丁杂质55Roxatidine Impurity 55
Roxatidine Impurity 55
CAS No.294180-37-3
Chemical FormulaC19H28N2O4
Purity>95%询价On request
10mg25mg50mg100mg
Roxatidine Impurity 56 structure
56
罗沙替丁杂质56Roxatidine Impurity 56
Roxatidine Impurity 56
CAS No.57611-57-1
Chemical FormulaC14H20N2O2
Purity>95%询价On request
10mg25mg50mg100mg
Roxatidine Impurity 58 structure
58
罗沙替丁杂质58Roxatidine Impurity 58
Roxatidine Impurity 58
CAS No.110271-85-7
Chemical FormulaC5H8O5
Purity>95%询价On request
10mg25mg50mg100mg
Roxatidine Impurity 59 structure
59
罗沙替丁杂质59Roxatidine Impurity 59
Roxatidine Impurity 59
CAS No.4764-13-0
Chemical FormulaC12H17NO
Purity>95%询价On request
10mg25mg50mg100mg
Roxatidine Impurity 60 structure
60
罗沙替丁杂质60Roxatidine Impurity 60
Roxatidine Impurity 60
CAS No.73152-41-7
Chemical FormulaC12H17NO
Purity>95%询价On request
10mg25mg50mg100mg
Roxatidine Impurity 66 structure
66
罗沙替丁杂质66Roxatidine Impurity 66
Roxatidine Impurity 66
CAS No.93138-55-7
Chemical FormulaC12H18N2
Purity>95%询价On request
10mg25mg50mg100mg
Roxatidine Impurity 68 structure
68
罗沙替丁杂质68Roxatidine Impurity 68
Roxatidine Impurity 68
CAS No.1461676-00-5
Chemical FormulaC6H8O7
Purity>95%询价On request
10mg25mg50mg100mg
Roxatidine Impurity 70 structure
70
罗沙替丁杂质70Roxatidine Impurity 70
Roxatidine Impurity 70
CAS No.1504061-73-7
Chemical FormulaC14H19NO3
Purity>95%询价On request
10mg25mg50mg100mg
Roxatidine Impurity 73 structure
73
罗沙替丁杂质73Roxatidine Impurity 73
Roxatidine Impurity 73
CAS No.85813-51-0
Chemical FormulaC34H50N4O5
Purity>95%询价On request
10mg25mg50mg100mg
Roxatidine Impurity 2-d10 (Roxatidine Acetate Hydrochloride-d10) structure
2-D10
罗沙替丁杂质2-d10(罗沙替丁醋酸盐-d10)Roxatidine Impurity 2-d10 (Roxatidine Acetate Hydrochloride-d10)
Roxatidine Impurity 2-d10 (Roxatidine Acetate Hydrochloride-d10)
CAS No.1794898-04-6
Chemical FormulaC19H18D10N2O4·HCl
Purity>95%询价On request

结构式清晰度以随货 COA 与厂家图谱为准;目录之外的杂质可按需定制合成或调取。Structural confirmation is governed by the COA and manufacturer spectra. Impurities outside this list can be custom-synthesised or sourced on request.

Literature & synthesis

罗沙替丁 —— 研究文献与合成路线Roxatidine — literature & synthetic routes

以下题录由公开学术数据库按品种名检索汇总,供 罗沙替丁 的杂质谱研究、分析方法开发与工艺路线选择参考。文献题名与专利标题均可点击查看原文,版权归原作者与出版方所有。Citations below are aggregated from public scholarly databases by drug-substance name, for reference in impurity profiling, analytical method development and route selection for Roxatidine. Titles link to the original records; copyright remains with the authors and publishers.

杂质与降解研究文献Impurity & degradation studies

  1. Roxatidine Attenuates Degradation of Extracellular Matrix
    Ze R, Wang S, Xie M, et al. · Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2017

合成与制备工艺专利Synthesis & process patents

  1. Synthesis process of roxatidine acetate hydrochloride
    LIU SHUFA WANG · 公开号 CN1986535CN1986535 · 2007
  2. Synthesis of roxatidine acetate
    XU ZHENG · 公开号 CN1490315CN1490315 · 2004
  3. Process for preparing high purity roxatidine acetate and its salts
    LIU KUN ZHANG · 公开号 CN1715276CN1715276 · 2006

题录与链接来自公开数据库 Europe PMC(含 PubMed 与全球专利题录)与 WIPO PatentScope,本站仅提供索引,不转载正文;如链接失效请以数据库检索为准。Citations are indexed from public databases (Europe PMC incl. PubMed and patent records, WIPO PatentScope); we provide links only and do not reproduce full text.

For formulation & analytical R&D

罗沙替丁 杂质谱研究要点Roxatidine — impurity profiling notes

下面这些是拿到 罗沙替丁 的 36 个杂质条目之后,仿制药研发最常遇到的几件事。先把杂质的来源分清,再决定要不要买对照品、买哪几个。Once you have the 36 impurity entries for Roxatidine, these are the questions that come up most in generic development. Classify the source of each impurity first, then decide which reference standards you actually need.

01工艺杂质Process impurities

起始物料、中间体、副产物、催化剂与溶剂残留。多来自合成路线本身,应在工艺开发阶段用加标试验定位。Starting materials, intermediates, by-products, catalysts and residual solvents — traced back to the synthetic route and located with spiking studies during process development.

02降解杂质Degradation impurities

水解、氧化、光解、高温高湿与聚合产物。需通过强制降解试验识别,并确认方法具备稳定性指示能力。Hydrolytic, oxidative, photolytic, thermal and polymeric degradants — identified through forced degradation, with the method proven stability-indicating.

03药典杂质Pharmacopoeial impurities

EP/USP 已收载并有官方编号的杂质(如 EP Impurity A、USP Related Compound B)。申报时通常需逐项对照。Impurities already monographed with official designations (e.g. EP Impurity A, USP Related Compound B), normally compared item by item during filing.

04基因毒性杂质Genotoxic impurities

含警示结构、需按 ICH M7 进行危害评估与限度推导(TTC 1.5 µg/日)。该类杂质必须用对照品准确控制。Structurally alerting compounds requiring ICH M7 hazard assessment and limit derivation (TTC 1.5 µg/day); these must be controlled with an authentic reference standard.

05同位素标记物Isotopically labelled standards

氘代、¹³C、¹⁵N 标记的同类物,主要用作 LC-MS/MS 生物分析的内标,抵消基质效应与回收率波动。Deuterated, ¹³C- and ¹⁵N-labelled analogues used as internal standards in LC-MS/MS bioanalysis to compensate matrix effects and recovery variation.

06代谢与转化产物Metabolites & conversion products

体内代谢物、强制降解转化物与工艺中间态,常见于杂质谱比对与稳定性考察中。In-vivo metabolites, forced-degradation products and process intermediates encountered in impurity profiling and stability studies.

方法开发与对照品使用建议Method development and standards usage

先定分离,再谈定量Resolution first, then quantification

主成分与相邻杂质峰分离度应 ≥1.5;用杂质对照品确定相对保留时间与相对响应因子,避免用自身对照法掩盖响应差异。Target baseline resolution ≥1.5 between the main component and adjacent impurities; establish relative retention and relative response factors with authentic impurity standards rather than relying on self-comparison.

校正因子不可忽略Never ignore response factors

紫外吸收差异大的杂质必须校正,否则定量结果系统性偏低或偏高。EP/USP 已给出校正因子的按药典执行。Impurities with markedly different UV response need correction, otherwise results are systematically biased. Where EP/USP publish a correction factor, follow the monograph.

强制降解要做全Run the full forced-degradation panel

建议覆盖酸、碱、氧化(H₂O₂)、光照(ICH Q1B)、高温高湿;主峰纯度用二极管阵列或质谱确认。Cover acid, base, peroxide oxidation, photostability (ICH Q1B) and heat/humidity; confirm peak purity by DAD or MS.

定义报告阈值Set reporting and identification thresholds

按 ICH Q3A/Q3B 设定报告阈值、鉴定阈值与界定阈值,避免为无意义的峰投入过多工作量。Apply ICH Q3A/Q3B reporting, identification and qualification thresholds so effort is not spent on insignificant peaks.

标准品储存有讲究Store standards properly

杂质对照品多建议 −20 ℃ 避光、干燥、密封保存;溶液现配现用,并记录开瓶与配制日期。Most impurity standards should be stored at −20 °C, protected from light and moisture; prepare solutions fresh and record opening and preparation dates.

用结构式先做初判Start from the structure

先比对杂质与主成分的结构差异,可预判其保留行为、紫外响应与可能的降解路径,能显著减少试错。Comparing the impurity structure with the parent drug predicts retention behaviour, UV response and probable degradation routes, cutting trial and error.

以上为通行的杂质研究实践提示,不针对具体品种给出结论。实际限度、校正因子与色谱条件请以 EP/USP 各论及你们的验证数据为准。需要某个杂质的结构确证资料、COA 或定制合成,可直接联系我们。The above are general impurity-profiling notes and are not conclusions about this specific drug substance. Actual limits, correction factors and chromatographic conditions follow the EP/USP monograph and your own validation data. Contact us for structural confirmation data, COAs or custom synthesis.
索取杂质谱报价 / COARequest a quote / COA← 查看其它品种← Other drug substances